BRADYCARDIA

This study tests a new pacing lead (Solia CSP S) placed in a specific area of the heart to treat slow heart rhythms. About 192 people will be enrolled to see if the lead is safe and works well over 3 months, with quality of life checked up to 12 months. The goal is to improve hea…

This study tests the safety and performance of a new pacemaker (Amvia) and a special lead (Solia CSP S) designed to pace the heart's natural electrical system more precisely. It involves 152 people who need a pacemaker or heart resynchronization therapy. Participants are followed…

This study is testing a new type of pacemaker that doesn't use wires (leads) to help control slow heartbeats. About 20 adults who need a pacemaker will get this device and be checked for safety and performance at 1 and 3 months. The goal is to see if the device works well and cau…

This study follows about 3,100 people who receive a Micra pacemaker to treat slow heart rate (bradycardia). Researchers want to confirm the device works safely and effectively in routine medical practice. Participants are monitored for up to 5 years to track complications and how…

This study follows about 37,000 Medicare patients who received a Micra leadless pacemaker for slow heart rate (bradycardia). Researchers use insurance claims data to check for complications within 30 days and survival rates over two years. The goal is to confirm the device's safe…

This study follows 37,000 Medicare patients who received a Micra AV leadless pacemaker or a traditional pacemaker to treat slow heart rate (bradycardia). Researchers will review insurance claims to compare complication rates and survival over two years. The goal is to gather real…

This study gathers information from 1,000 adults who have or will receive a cardiac implantable electronic device (CIED) for heart rhythm problems like bradycardia or tachycardia. Researchers will collect data on the devices, implant procedures, and patient characteristics to hel…